HRS4R
Vull donar

GEMMA OSCA GELIS

Firma
GEMMA OSCA-GELIS
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2

Projectes

Codi oficial: La Marató 201906-30 Data inici: 30/09/2020 Data fi: 29/09/2023 Investigador/a principal: JOAQUIM BOSCH BARRERA Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 109,562.50 €

Publicacions

Rubió-Casadevall J, Carbó-Bagué A, Puigdemont M, Osca-Gelis G, Oliveras G, Vilar-Coromina N, Ferrer-Fabrega B, Urban A, Llobet-Roma M, Martín-Romero F, Perez-Bueno F, Marcos-Gragera R

Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor.

EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31, 616-622 dx.doi.org/10.1684/ejd.2021.4136

Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D, on the behalf of CETLAM Group

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy.

Leukemia, 2020, 34, 2925-2933 dx.doi.org/10.1038/s41375-020-0784-2

Fort Culillas, R., Carmona Garcia, C., Osca Geli, G., Marcos-Gragera, R., Puigdemont Guinart, M., Biarnes Costa, J., Lopez-Ben, S., Garcia Velasco, A., Guardeno Sanchez, R.

Incidence and survival of pancreatic neuroendocrine tumours in Girona, Spain

ANNALS OF ONCOLOGY, 2020, 31, 169-169 dx.doi.org/10.1016/j.annonc.2020.04.325

Solans M, Osca-Gelis G, Comas R, Roncero JM, Gallardo D, Marcos-Gragera R, Saez M

Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.

CANCER CAUSES & CONTROL, 2018, 29, 379-382 dx.doi.org/10.1007/s10552-018-1004-5

Rubió-Casadevall J, Borràs JL, Carmona C, Ameijide A, Osca G, Vilardell L, Izquierdo A, Galceran J, Marcos-Gragera R

Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16, 660-667 dx.doi.org/10.1007/s12094-013-1131-0

Puig-Vives M, Osca-Gelis G, Camprubí-Font C, Vilardell ML, Izquierdo A, Marcos-Gragera R

Proporción de cáncer de mama en mujeres de 50 a 69 años de Girona según el método de detección.

MEDICINA CLINICA, 2014, 143, 300-302 dx.doi.org/10.1016/j.medcli.2013.09.042

Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R, EUROCARE-5 Working Group

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

LANCET ONCOLOGY, 2014, 15, 931-942 dx.doi.org/10.1016/S1470-2045(14)70282-7

Formulari de contacte

Coneix l’IDIBGI!

menu